Tumour cells are sensitised to ferroptosis via RB1CC1‐mediated transcriptional reprogramming

Abstract

Our findings indicate that RB1CC1-associated signalling sensitises tumour cells to ferroptosis and that targeting RB1CC1 may be beneficial for tumour treatment.